To Get Help Now
Personal Injury Lawsuits
Click Here
 
Today's Date:

Remington Model 700 and Remington Model Seven Rifles Recalled Due to Risk of Unintentional Discharge

Gun manufacturer Remington has announced a safety recall of Model 700 and Model Seven rifles. The rifles affected by the recall have a X-Mark Pro, or XMP triggers and were manufactured between May 1, 2006 and April 9, 2014.

The recall was issued after Remington found out that rifles equipped with the XMP trigger can fire unintentionally, according to Gunds.com. The issue is very dangerous and could prove fatal if not addressed. Remington said the issue is specific to the XMP trigger only, and all other Model 700 and Model Seven rifles are unaffected by the recall. More Remington Model 700 and Remington Model Seven Rifles Recalled Due to Risk of Unintentional Discharge

EU Regulators Reviewing Testosterone Medication Heart Risks

The European Medicines Agency is reviewing testosterone medications after studies suggested the drugs may be linked to cardiovascular risks.

The European Union’s (EU) drug regulator will study the benefits and risks of testosterone products and conclude whether the marketing for the medications should be maintained, altered, suspended, or withdrawn, Bloomberg.com reported. More EU Regulators Reviewing Testosterone Medication Heart Risks

Texas Family Tells Jury of Air Quality Poisoned by Local Natural Gas Drilling

A Texas family told a Dallas jury on Tuesday that they are being sickened by natural gas wells near their property that are owned by Texas-based Aruba Petroleum, Inc.  A $9 million nuisance lawsuit filed against the company by the family is one of the first trials seeking to hold a company liable for medical problems allegedly linked to chemicals used in fracking.

The Parr family alleges that Aruba Petroleum exposed them to dangerous chemicals, gases, and industrial waste at some of the company’s 22 gas wells drilled near their 40-acre property in Wise County. They allege they’ve suffered numerous health problems, some of them so severe that they were unable to work and were forced to live in Bob Parr’s office instead of their home. The Parrs say their medical problems were caused by benzene, toluene, ethylbenzene, xylene and other volatile organic compounds from the drilling sites, according to Law360.com. More Texas Family Tells Jury of Air Quality Poisoned by Local Natural Gas Drilling

Janssen Pharmaceuticals Settles 76 Topamax Birth Defects Cases

Johnson & Johnson (J&J) has settled with 76 plaintiffs who alleged birth defects in the babies of women who took the anti-epilepsy and migraine drug Topamax during their pregnancies.

Judge Arnold New filed an order last Tuesday marking 76 of the cases as discontinued after receiving confirmation that the plaintiffs had reached settlement agreements with J&J’s Janssen Pharmaceuticals unit. Judge New is coordinating a mass tort docket of Topamax cases in the Philadelphia Court of Common Pleas, according to Law360.com. More Janssen Pharmaceuticals Settles 76 Topamax Birth Defects Cases

Battery Defect in Ventilators puts Patients at Risk for Unexpected Lapse in Ventilation

Evita V500 and Babylog VN500 ventilators are being recalled by the Pennsylvania-based company, Draeger Medical, due to battery issues that could put patients at risk. The U.S. Food and Drug Administration (FDA) gave the recall their highest-risk Class I label.

The batteries installed in the Evita V500 and the Babylog VN500 ventilators may suddenly fail without triggering alarms or indicating a low battery supply, which puts patients at risk for an unexpected lapse in ventilation that could result in injury or death. There may be no indication of a diminished battery until all power is lost, according to MassDevice.com More Battery Defect in Ventilators puts Patients at Risk for Unexpected Lapse in Ventilation

Thoratec’s HeartMate II Implantable Heart Pump is Subject of Class I Recall

The U.S. Food and Drug Administration (FDA) has issued a Class I recall of Thoratec’s HeartMate II implantable heart pump.  A Class I is the agency’s most serious recall classification and is reserved for devices that have the potential to kill or seriously injure patients.

Five patients have been injured by the HeartMate II and four deaths were reportedly associated with a defect in the heart pump’s controllers. According to the company’s warning, the dead and injured patients did not receive adequate training on how to switch from an old controller to a new one. The controllers help circulate blood throughout the body, allowing the heart – which may be too weak to pump the blood on its own – to work less, MassDevice.com reported. More Thoratec’s HeartMate II Implantable Heart Pump is Subject of Class I Recall

Coloplast Agrees to Pay $16 Million to Settle Pelvic Mesh Lawsuits

Medical device maker Coloplast has agreed to pay about $16 million to settle lawsuits filed against the company by women who allege they were injured by its pelvic mesh products.

The Denmark-based company agreed in January to resolve about 400 lawsuits filed over the mesh inserts, which would provide a payment of approximately $40,000 for each claimant, according to Bloomberg.com. More Coloplast Agrees to Pay $16 Million to Settle Pelvic Mesh Lawsuits

Fitbit Faces Consumer Class-Action Lawsuit over its Recalled Force Fitness Trackers

Fitbit, the maker of Fitbit Force fitness trackers, is facing a class-action lawsuit over the devices, which caused rashes and skin irritations in 1.7 percent of users.

The lawsuit, filed last Monday in the Superior Court of California in the County of San Diego, seeks class-action status and accuses the company of misleading consumers in its promotion and advertising of the Force, which is designed to allow users to track their sleep and activity, and then sync the data up to a computer or smartphone for review, according to the Wall Street Journal (WSJ). More Fitbit Faces Consumer Class-Action Lawsuit over its Recalled Force Fitness Trackers

Testosterone Therapy Allegedly Caused Heart Attack, Testim Lawsuit Filed

A Vineland, New Jersey couple is suing Auxilium Pharmaceuticals Inc. and Philadelphia’s GlaxoSmithKline for an injury the husband alleges was caused by the companies’ testosterone replacement drug, Testim.

According to the complaint filed in Philadelphia’s Common Pleas Court, Edwin Rios believed he was suffering from “Low T,” an alleged condition that causes symptoms such as low sex drive, fatigue, irritability, and loss of muscle mass. The complaint alleges that Auxilium and GlaxoSmithKline knew that a decrease in testosterone levels in men is a normal part of the aging process and that unnaturally restoring testosterone puts men at risk for cardiovascular events, according to PennRecord.com More Testosterone Therapy Allegedly Caused Heart Attack, Testim Lawsuit Filed

Attorney General Sues Makers of Plavix, Alleges Deceptive and Unfair Marketing and Labeling

Hawaii Attorney General (AG) David M. Louie filed a complaint against Bristol-Myers Squibb Co. and Sanofi-Aventis US LLC in state court on Wednesday alleging the drug companies deceptively and unfairly labeled and marketed its blood thinner, Plavix.

According to the complaint, the companies didn’t reveal that Plavix has little or no impact on the 30 percent of the population who metabolize the drug poorly because of their genetic traits or because they take other drugs, Law360.com reported. More Attorney General Sues Makers of Plavix, Alleges Deceptive and Unfair Marketing and Labeling